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Objective: Patients undergoing reoperative coronary artery bypass have increased
mortality and morbidity compared with those undergoing primary coronary bypass.
The experience in applying off-pump techniques to coronary reoperations is limited.
In this article we report a 10-year experience using various techniques of reoperative
off-pump coronary bypass.
Methods:Between January 1996 and December 2005, 332 patients underwent reoper-
ative off-pump coronary artery bypass grafting. Data were collected regarding the pre-
operative, intraoperative, and postoperative clinical course of all patients. These were
compared with similar data obtained from patients who had undergone conventional
coronary reoperation during this period.
Results: Two hundred ninety-six (89.2%) male and 36 female patients underwent re-
operative off-pump coronary artery bypass. Of these, 265 (79.8%) patients underwent
multivessel bypass through a median sternotomy, an anterolateral thoracotomy was
performed in 63 (19%) patients, and a posterolateral thoracotomy was performed in
4 (1.2%) patients. The early mortality for patients undergoing off-pump surgery was
lower than for those undergoing conventional reoperations (3.3% vs 5.5%, P 5
.066). Those who had undergone off-pump reoperations had less need for prolonged
ventilation or prolonged inotropic support and had shorter intensive care unit and hos-
pital stays than patients who had undergone redo coronary artery bypass grafting.
Conclusion: For many patients requiring coronary reoperations, off-pump techniques
are safe and feasible. Complete revascularization was achieved in at least 75% of pa-
tients in an unselected population, with mortality and perioperative event rates that are
comparable with those of conventionally performed coronary reoperations.
C
oronary artery bypass grafting (CABG) is a well-established therapy for pa-
tients with coronary artery disease, and the results of primary operations
are relatively good. However, many patients have recurrent symptoms, and
some require reoperation. Although some authors have observed similar rates of
mortality and morbidity for both primary coronary artery surgery and reoperative
coronary bypass,1 many other groups have found that mortality and morbidity are
higher during coronary reoperation.2,3 Traditionally, coronary reoperation has been
performed during cardiopulmonary bypass with the aorta crossclamped and the heart
arrested by means of cardioplegia (redo CABG). Recently, techniques of performing
coronary artery surgery off pump have been developed. At this institution, we are
routinely performing primary off-pump CABG (OPCABG),4 with excellent results.5
The reports of the application of off-pump techniques to coronary reoperations (redo
OPCABG) for either single-vessel or multivessel disease are few.6-10 The aim of
this retrospective study was to analyze our experience with redo OPCABG.
Materials and Methods
Study Population
From January 1996 until December 2005, reoperative coronary artery bypass was performed on
538 patients at this institution. Of these, 332 underwent redo OPCABG, of whom 296 (89.2%)
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weremale and 36 (10.8%) were female; these patients are the subject
of this study. During this period, 206 patients (183 [88.8%] male and
23 [11.2%] female patients) underwent redo CABG. The different
surgical approaches, as well as the revascularization procedures,
used in the redo OPCABG group are presented in Table 1. All pa-
tients had symptomatic coronary artery disease that could not be
managed by using medical therapy. Apart from routine investiga-
tions, specific preoperative studies included coronary angiography,
transthoracic echocardiography, pulmonary function testing, poster-
oanterior and lateral chest radiography, and, more recently, contrast-
enhanced computed tomography of the chest.
Choice of Technique
The selection of patients to receive redo OPCABG or redo CABG
was left to the discretion of the operating surgeons, all of whom
were experienced in both procedures. The factors influencing the
decision to perform the procedure on pump included worse hemo-
dynamic status, increased urgency of the operation, and worse qual-
ity of distal coronary target vessels.
Selection of Surgical Approach
Median sternotomy. All patients planned for multivessel revas-
cularization underwent sternotomy.
Anterolateral thoracotomy. Anterolateral thoracotomy was
used as a technique to avoid the morbidity of sternal re-entry, espe-
cially in sicker, often older patients with additional comorbidities
who required left anterior descending coronary artery (LAD) by-
pass, and as an elective, minimally invasive procedure for those
who required LAD grafting.
Posterolateral thoracotomy. Posterolateral thoracotomy was
used for grafting the obtuse marginal vessels in patients with patent
left internal thoracic artery (LITA)–LAD grafts.
Surgical Technique
Median sternotomy was the surgical approach used in 265 cases.
The redo sternotomy and mediastinal dissection were performed
as recommended previously,11 essentially by using an oscillating
saw, initial exposure of the aorta and right atrium, the ‘‘no-touch’’
technique for previously placed grafts, and careful progression of
the dissection on the left ventricle to identify and preserve previ-
ously placed thoracic artery–coronary artery grafts. The entire heart
was mobilized in all cases. Indications for conversion to redo CABG
included bleeding at sternal re-entry, hemodynamic instability dur-
ing mediastinal dissection, or the finding of small-caliber, diffusely
diseased coronary targets, rendering off-pump methods technically
difficult. The patient was given 3 mg/kg heparin. To facilitate distal
anastomosis, use was made of commercially available suction-based
cardiac stabilization devices, and a CO2 blower and intraluminal
shunts were used routinely. The proximal aortic anastomoses were528 The Journal of Thoracic and Cardiovascular Surgery c Marperformed by using a partial, side-biting, atraumatic vascular clamp.
The effects of heparin were reversed with protamine, and graft flows
were checked with Doppler probes. The redo CABG procedure was
performed during aortic crossclamping with both antegrade and
retrograde delivery of cold blood (4:1) cardioplegia, moderate
systemic hypothermia, and a terminal hot shot.
Anterolateral thoracotomy. After institution of double-lumen en-
dotracheal intubation, the patient was placed in the right lateral decu-
bitus position with the pelvis externally rotated to 45 to allow access
to the femoral artery. A small skin incision was made along the fifth
intercostal space between the nipple and the midaxillary line, and
the fifth intercostal space was opened. The thoracotomywas extended
anteriorly or posteriorly to facilitate the operation. With the lung
deflated, the LITAwas harvested, as described elsewhere.12 The peri-
cardium was then opened anterior to the phrenic nerve. Limited adhe-
siolysis, sufficient to expose the target vessels, was performed, and
then the anastomosis was performed by using standard techniques.
Posterolateral thoracotomy. The fifth intercostal space was used
to enter the chest. The pericardiumwas palpated to locate and avoidold
vein grafts if present andwas opened posterior to the phrenic nerve.Af-
ter distal anastomosis, proximal anastomosis was performed on the
descending aorta by routing the grafts anterior to the pulmonary hilum.
Data were collected regarding the preoperative, intraoperative,
and postoperative clinical course of all patients. The operative notes
were used to evaluate the choice and number of grafts. Periopera-
tive myocardial infarction was defined as any new Q wave or loss
of R wave on the electrocardiogram or a significant increase in cre-
atine kinase–myocardial fraction levels (.40 U/L). Postoperative
TABLE 1. Operative details of patients undergoing redo
OPCABG
Median sternotomy (n 5 265)
Mean no. of grafts per patient 2.17 6 0.74
No. of grafts
1 71 (26.7%)
2 87 (32.9%)
3 98 (37%)
4 9 (3.4%)
Conduits
LITA 151 (56.8%)
RSVG 212 (80%)
Radial artery 119 (6.3%)
RGEA 1 (0.3%)
Intraoperative IABP insertion 21 (8%)
Need for CPB 29 (11%)
Anterolateral thoracotomy (n 5 63)
LITA–LAD 55 (83.3%)
LITA–LAD 1 PTCA 4 (6.3%)
LITA–LAD 1 TMLR 4 (6.3%)
Posterolateral thoracotomy (n 5 4)
RSVG–OM 4 (6.3%)
OPCABG, Off-pump coronary artery bypass grafting; LITA, left internal tho-
racic artery; RSVG, reverse saphenous venous graft; RGEA, right gastroepi-
ploic artery; IABP, intra-aortic balloon pump; CPB, cardiopulmonary bypass;
LAD, left anterior descending coronary artery; PTCA, percutaneous coro-
nary angioplasty; TMLR, transmyocardial laser revascularization; OM,
obtuse marginal.ch 2008
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bleeding. Cerebrovascular accident was defined as a coma lasting
longer than 24 hours, transient ischemic attack, or neurologic def-
icit lasting longer than 72 hours. Renal failure includes both an
increase of serum creatinine value to twice preoperative levels
and a need for dialysis. The patients who required intraoperative
conversion from redo OPCABG to redo CABG were included in
the redo CABG group for final analysis.
Statistical analysis was performed with SPSS software (SPSS,
Inc, Chicago, Ill). All clinical data are expressed as means 6 stan-
dard deviations. Categorical values were compared by means of
the c2 test, and the Mann–Whitney test was used to calculate the dif-
ferences in continuous variables between the 2 groups. The mean
number of grafts per patient in each group was compared by using
the paired Student t test.
The use of these data for research was approved by the institu-
tional review board.
Results
Feasibility of Redo OPCABG
Five hundred thirty-eight patients had coronary reoperations
during the 10-year study period. Of these, 332 (61.7%) under-
went redo OPCABG, with 265 (79.8%) patients undergoing
bypass through a median sternotomy, 63 (19%) patients un-
dergoing bypass though an anterolateral thoracotomy, and
4 (1.2%) patients undergoing posterolateral thoracotomy
(Table 1). The preoperative characteristics of this unselected
patient population (Table 2) reveal that redo OPCABG is fea-
sible in most patients, regardless of the coexisting disease or
the urgency of clinical presentation. Note that 35.5% required
urgent operations, 7.6%had an intra-aortic balloon pump, and
16% had significant left main disease. Preoperatively planned
redo OPCABG required intraoperative conversion to redo
CABG in only 11% of cases, and in only 8% of cases was in-
stitution of intra-aortic balloon pump support needed. There
was no difference in outcome between patients requiring in-
traoperative conversion to redo CABG and those preopera-
tively selected for redo CABG. An average of 2.17 grafts
per patient could be placed in those requiring multivessel by-
pass, with 57% receiving LITA–LAD anastomoses (Table 3).
In the group undergoing anterolateral thoracotomy, all 68 pa-
tients received LITA–LADgrafts without the need for cardio-
pulmonary bypass.
Safety of Redo OPCABG
Hospital mortality was 3.3% (11 patients) in the median ster-
notomy group (Table 4), and 1 patient died after anterolateral
thoracotomy. In the multivessel redo OPCABG group, mor-
bidity also was low: postoperative myocardial infarction,
4.8%; renal failure, 0.6%; cerebrovascular accident, 0%;
and prolonged ventilation, 7.5%.
Discussion
The large number of isolated primary CABG procedures
performed in the 1980s and 1990s increased the incidenceThe Journal of Thoof patients requiring reoperative coronary bypass in these
decades.3 In recent years, however, the number of patients
undergoing coronary reoperation has reached a plateau in
some institutions (Figure 1).1,2 This is the result of routine
use of the LITA for grafting of the LAD, better management
TABLE 2. Preoperative characteristics
Variable
Redo OPCABG
(n 5 332)
Redo CABG
(n 5 206)
Age (y 6 SD) 60.4 6 5.8 61.2 6 6.1
Female sex (%) 36 (10.8%) 23 (11.2%)
Unstable angina 116 (34.9%) 89 (43.2%)
Previous myocardial infarction 153 (46.1%) 101 (49%)
Congestive heart failure 23 (6.9%) 10 (4.9%)
Peripheral vascular disease 19 (5.7%) 7 (3.4%)
Aortic atheroma 28 (8.4%) 15 (7.3%)
Prior cerebrovascular accident 12 (3.6%) 5 (2.4%)
Chronic obstructive pulmonary disease 25 (7.5%) 17 (8.2%)
Renal failure 5 (1.5%) 3 (1.4%)
Diabetes 108 (32.5%) 64 (31.1%)
Hypertension 159 (47.9%) 108 (52.4%)
Smoker 55 (16.6%) 35 (17%)
Interval from previous bypass (mo) 89 6 17 79 6 14
Previous use of LITA 101 (30.8%) 68 (33%)
Preoperative intra-aortic balloon pump 26 (7.8%) 19 (9.2%)
Emergency operation 118 (35.5%) 91 (44.2%)
Preoperative ejection fraction
(mean 6 SD)
42.6 6 6.8 43.1 6 6.6
Vessels diseased
Single 5 (1.5%) 0 (0%)
Double 56 (16.9%) 38 (18.5%)
Triple 271 (81.6%) 168 (81.5%)
Left main disease 53 (16%) 44 (21.4%)
OPCABG, Off-pump coronary artery bypass grafting; CABG, coronary artery
bypass grafting; SD, standard deviation; LITA, left internal thoracic artery.
TABLE 3. Operative details of the patients undergoing
median sternotomy
Variable
Redo OPCABG
(n 5 265)
Redo CABG
(n 5 206) P value
Mean grafts per patient 2.17 6 0.74 2.51 6 0.66 .265
No. of grafts
1 71 (26.7%) 17 (8.3%) .065
2 87 (32.9%) 78 (37.9%) .213
3 98 (37%) 101 (49.0%) .311
4 9 (2.7%) 10 (4.8%) .756
Conduits
LITA 151 (56.8%) 125 (60.6%) .673
Radial artery 119 (44.9%) 156 (75.7%) .05
RSVG 212 (80%) 195 (94.7%) .686
RGEA 2 (0.6%) 1 (0.5%) 1.00
OPCABG, Off-pump coronary artery bypass grafting; CABG, coronary artery
bypass grafting; LITA, left internal thoracic artery; RSVG, reverse saphenous
vein graft; RGEA, right gastroepiploic artery.racic and Cardiovascular Surgery c Volume 135, Number 3 529
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and statin therapy. Hence patients who require coronary reop-
erations are currently older, with more extensive coronary ar-
tery disease and poorer left ventricular function.2
Despite technical improvements and increased surgical
experience, most series of coronary reoperations report
higher rates of mortality and morbidity compared with pri-
mary operations, in the range of 4% to 16%.13 There are sev-
eral factors that contribute to this: hazards during sternal
re-entry, hemodynamic instability during mediastinal dissec-
tion, inadvertant damage to patent grafts, ischemia caused
by embolization of atheromatous debris from venous con-
duits, and inadequate myocardial protection caused by diffi-
culties in delivering cardioplegia in the face of native and
conduit stenoses. Additionally, parallel to progression of
coronary artery disease, there might be more extensive aortic
atherosclerotic disease.14
OPCABG aims at complete revascularization without
subjecting the patient to the ill effects of extracorporeal circu-
TABLE 4. Postoperative outcomes
Outcome Redo OPCABG Redo CABG
Mortality 11 (3.3%) 12 (5.8%)
CVA 0 (0.0%) 3 (1.4%)
Postoperative MI 16 (4.8%) 15 (7.3%)
Postoperative bleeding 7 (2.1%) 9 (4.4%)
Atrial fibrillation 12 (3.6%) 16 (7.8%)
Renal failure 2 (0.6%) 5 (2.4%)
Patients requiring transfusions (%) 46 (13.6%) 173 (84%)
Prolonged ventilation (.24 h) 25 (7.5%) 35 (17%)
Need for inotropes .48 h 38 (11.4%) 49 (23.8%)
ICU stay (h) 21 6 4 38 6 6
Hospital stay (d) 5 6 3 9 6 4
OPCABG, Off-pump coronary artery bypass grafting; CABG, coronary artery
bypass grafting; CVA, cerebrovascular accident; MI, myocardial infarction;
ICU, intensive care unit.
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Figure 1. Depiction of the increasing trend toward redo off-pump
coronary artery bypass grafting (OPCABG) at this institution.
CABG, Coronary artery bypass grafting.530 The Journal of Thoracic and Cardiovascular Surgery c Malation, cardioplegia, or aortic cannulation. Some benefits of
OPCABG over CABG at primary operation have been noted:
decreased incidence of atrial fibrillation, transfusion needs,
inotrope requirements, respiratory infections, ventilation
time, intensive care unit stay, and hospital stay.15 However,
concerns regarding the completeness of revascularization
and graft patency remain.
There are few published reports of the application of off-
pump techniques to coronary reoperations. Many of these
pertain to single-vessel coronary targets,16,17 and experience
with multivessel redo OPCABG is limited.6-9
This report documents the largest and most comprehen-
sive experience of the use of off-pump techniques for reoper-
ative coronary artery bypass. Compared with patients usually
encountered in North America, our patient cohort is younger
and thus perhaps at less risk during coronary reoperation, and
this fact could have influenced our results. Nonetheless,
although this is a retrospective and nonrandomized study in
which surgeons selected the choice of procedure, we believe
that the large and unselected patient population described
helps to establish the safety and feasibility of redo OPCABG
for routine clinical use.
Safety and Feasibility
We have shown that redo OPCABG can be performed safely
in 61.7% of patients presenting for coronary reoperation,
regardless of the comorbid disease, and in a wide range of
clinical presentations of the patient. The overall mortality
of 3.3% in our patients compares favorably with that of
most published studies on conventionally performed coro-
nary reoperation. Sabik and colleagues1 reported a mortality
rate of 4.4% for their patients undergoing first reoperation;
Di Mauro and associates7 reported that their mortality rate
was 4.2%. We have also found that among our patients,
the performance of redo OPCABG results in low rates of
perioperative myocardial infarction, renal failure, and cere-
brovascular accidents and allows for reasonably swift recov-
ery of these patients. The present study was not designed to
be a true comparison of outcome between redo OPCABG
and redo CABG. We sought to establish the safety and effi-
cacy of redo OPCABG in a large series of patients undergo-
ing coronary reoperation, especially in light of the limited
worldwide experience with this technique. The comparison
presented sheds some light on the spectrum of cases that
can be performed safely by using off-pump techniques.
However, other authors have compared redo OPCABG
with redo CABG directly.6-9 In all of these studies, the trend
is toward a reduction in mortality and morbidity in the redo
OPCABG groups. It merits emphasis, however, that in all of
these studies, patients were not randomized to receive either
procedure, and criteria for selection for redo OPCABG was
variable. Moreover, these were small studies, and hence
these trends have not become statistically significant. Re-
cently, blood transfusion requirements have been shown torch 2008
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the studies could show a significant difference in atrial fibril-
lation, renal function, cerebrovascular accident, or other
minor adverse clinical parameters.
Adequateness of Revascularization
Complete revascularization is the main goal of primary coro-
nary bypass, and it is reasonable to assume the same is true
of coronary reoperation. Studies have demonstrated that in-
complete myocardial revascularization negatively affects out-
come after primary operations.19 Themain concerns regarding
primary OPCABG involve completeness of revascularization
achieved and graft patency. In the setting of coronary reopera-
tion, Di Mauro and associates7 found higher rates of in-
complete revascularization in patients undergoing redo
OPCABG (17.7% vs 5.9%, P , .01) when compared with
redo CABG and showed that incomplete revascularization
was an independent risk factor for cardiac death and cardiac
mortality at 5 years. Tugtekin and coworkers8 used the index
of completeness of revascularization (preoperative planned/
performed anastomosis) to compare redo CABGand redoOP-
CABG.They found a higher incidence of complete revascular-
ization in their redo CABG group (86.9% for redo CABG vs
48.6% for redo OPCABG, P , .01). In the study by Czerny
and colleagues,6 in which redo OPCABG was targeted to cul-
prit coronary targets (target vessel revascularization), because
of significant difference in completeness of revascularization,
a higher incidence of recurrent angina was noted during a
5-year follow-up period. From these studies, there is some ev-
idence of less complete revascularization when performing
coronary reoperations by using off-pump techniques.
The application of a thoracotomy approach toward coro-
nary reoperations appears to be more accepted.20,21 After pri-
mary bypass, progression of disease and venous graft attrition
often lead to a situation in which a reoperative bypass is re-
quired in the presence of patent internal thoracic artery grafts.
The posterolateral thoracotomy approach allows revasculari-
zation of the obtuse marginal vessels while avoiding the haz-
ards of sternal re-entry, with its potential for injury to the
patent grafts. Additionally, in cases in which a vein graft
might have been placed on the LAD during the first operation,
the anterolateral thoracotomy approach allows LITA–LAD
grafting without sternal re-entry. Furthermore, this approach
also allows for the performance of hybrid revascularization
safely, as well as transmyocardial laser revascularization.22
Certain limitations of this study must be addressed. This
was a nonrandomized retrospective study that has allowed
the feasibility of redo OPCABG to be established. However,
a true comparison of redo OPCABG with redo CABG would
require a randomized controlled trial with well-defined crite-
ria for selection of patients for redo OPCABG. These studies
are necessary to obtain evidence as to which preoperative
factors could predict preoperatively that a patient would
have a successful off-pump procedure.The Journal of ThoIn summary, this report describes the versatility of the
various techniques of redo OPCABG and demonstrates that
for a majority of patients requiring coronary reoperations,
off-pump techniques are safe and feasible. Complete revas-
cularization was achieved in at least 75% of patients in an
unselected population, with mortality and perioperative event
rates that are comparable with those of conventionally
performed coronary reoperation.
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